Xeno Start
Biotechnology, 7703 Floyd Curl Dr, San Antonio, Texas, 78229, United States, 51-200 Employees
Phone Number: +12*********
Who is XENOSTART
XenoSTART is an industry-leading oncology translational research organization focused on the development and utilization of PDX models. Founded in 2007, XenoSTART was created in close col...
Read More
-
Headquarters: 7703 Floyd Curl Dr, San Antonio, Texas, 78229, United States
-
Date Founded: 2007
-
Employees: 51-200
-
Revenue: $500 Million to $1 Billion
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8011; 8099
|
NAICS Code: 621111 |
Show More
XenoSTART Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding XenoSTART
Answer: XenoSTART's headquarters are located at 7703 Floyd Curl Dr, San Antonio, Texas, 78229, United States
Answer: XenoSTART's phone number is +12*********
Answer: XenoSTART's official website is https://xenostart.com
Answer: XenoSTART's revenue is $500 Million to $1 Billion
Answer: XenoSTART's SIC: 8011; 8099
Answer: XenoSTART's NAICS: 621111
Answer: XenoSTART has 51-200 employees
Answer: XenoSTART is in Biotechnology
Answer: XenoSTART contact info: Phone number: +12********* Website: https://xenostart.com
Answer: XenoSTART is an industry-leading oncology translational research organization focused on the development and utilization of PDX models. Founded in 2007, XenoSTART was created in close collaboration with The START Center, an international cancer treatment and research organization. This partnership provides the unique ability to generate clinically-relevant XenoSTART patient-derived xenograft (XPDX) models. Our diverse repository of XPDX (XenoSTART PDX) models are clinically annotated and include patient treatment history and outcome. The models are characterized through genomic profiling, histologic analysis, next generation sequencing, and in vivo drug sensitivity to relevant standards of care. Our models can accelerate preclinical discovery and drug development through the following turn-key services: In vivo PK/PD and efficacy studies In-licensing of models for proprietary studies Orthotopic and radiotherapy studies [collaboration with our partners] Ex vivo and organoid studies [collaboration with our partners] In vivo efficacy panel screens [indication or target focused] Cell line development Custom model development
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month